Foscarnet-related Hypercalcemia During CMV Treatment in an Infant With SCID: A Case Report and Review of Literature

Foscarnet is a main treatment for disseminated cytomegalovirus infection in immunocompromised patients. One of its documented side effects is hypocalcemia. Hypercalcemia, in contrast, was described anecdotally before, almost exclusively in adults with human immunodeficiency virus infection or posttr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of pediatric hematology/oncology 2017-04, Vol.39 (3), p.e173-e175
Hauptverfasser:	Rabinowicz, Shira, Somech, Raz, Yeshayahu, Yonatan
Format:	Artikel
Sprache:	eng
Schlagworte:	Bone Matrix - metabolism Cytomegalovirus Infections - drug therapy Foscarnet - administration & dosage Foscarnet - metabolism Humans Hypercalcemia - chemically induced Hypercalcemia - etiology Infant Interleukin-7 Receptor alpha Subunit - deficiency Severe Combined Immunodeficiency - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!